Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dipa Jayaseelan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Muscle & Nerve|September 2, 2022
COVID-19 infection and vaccination in patients with skeletal muscle channelopathiesVinojini Vivekanandam, Dipa Jayaseelan, Michael G Hanna
Handbook of Clinical Neurology|August 10, 2023
Muscle channelopathiesVinojini Vivekanandam, Dipa Jayaseelan, Michael G Hanna
Brain : a Journal of Neurology|November 16, 2022
In silico versus functional characterization of genetic variants: lessons from muscle channelopathiesVinojini Vivekanandam, Rebecca Ellmers, Dipa Jayaseelan, et al.
Neuromuscular Disorders : NMD|November 7, 2025
Long term safety and efficacy of lamotrigine in patients with non-dystrophic myotonia, a single-centre prospective studyMurva Asad, Iwona Skorupinska, Natalie James, et al.
Practical Neurology|March 14, 2024
Kennedy's diseaseHelen Devine, Matthew Solomons, Luca Zampedri, et al.
Muscle & Nerve|July 29, 2023
Muscle MRI in periodic paralysis shows myopathy is common and correlates with intramuscular fat accumulationVinojini Vivekanandam, Karen Suetterlin, Emma Matthews, et al.
Neuromuscular Disorders : NMD|February 16, 2023
Prevalence of genetically confirmed skeletal muscle channelopathies in the era of next generation sequencingVinojini Vivekanandam, Rawan Jaibaji, Richa Sud, et al.
Brain : a Journal of Neurology|September 16, 2021
Translating genetic and functional data into clinical practice: a series of 223 families with myotoniaKaren Suetterlin, Emma Matthews, Richa Sud, et al.
Neurology|November 26, 2024
Functional Outcome Measures to Optimize Drug Development in Spinal and Bulbar Muscular Atrophy: Results From a Meta-Analysis of the Global SBMA DatasetSpencer B Huggett, Andrew T N Tebbenkamp, Carlo Rinaldi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Muscle & Nerve|September 2, 2022
COVID-19 infection and vaccination in patients with skeletal muscle channelopathiesVinojini Vivekanandam, Dipa Jayaseelan, Michael G Hanna
Handbook of Clinical Neurology|August 10, 2023
Muscle channelopathiesVinojini Vivekanandam, Dipa Jayaseelan, Michael G Hanna
Brain : a Journal of Neurology|November 16, 2022
In silico versus functional characterization of genetic variants: lessons from muscle channelopathiesVinojini Vivekanandam, Rebecca Ellmers, Dipa Jayaseelan, et al.
Neuromuscular Disorders : NMD|November 7, 2025
Long term safety and efficacy of lamotrigine in patients with non-dystrophic myotonia, a single-centre prospective studyMurva Asad, Iwona Skorupinska, Natalie James, et al.
Practical Neurology|March 14, 2024
Kennedy's diseaseHelen Devine, Matthew Solomons, Luca Zampedri, et al.
Muscle & Nerve|July 29, 2023
Muscle MRI in periodic paralysis shows myopathy is common and correlates with intramuscular fat accumulationVinojini Vivekanandam, Karen Suetterlin, Emma Matthews, et al.
Neuromuscular Disorders : NMD|February 16, 2023
Prevalence of genetically confirmed skeletal muscle channelopathies in the era of next generation sequencingVinojini Vivekanandam, Rawan Jaibaji, Richa Sud, et al.
Brain : a Journal of Neurology|September 16, 2021
Translating genetic and functional data into clinical practice: a series of 223 families with myotoniaKaren Suetterlin, Emma Matthews, Richa Sud, et al.
Neurology|November 26, 2024
Functional Outcome Measures to Optimize Drug Development in Spinal and Bulbar Muscular Atrophy: Results From a Meta-Analysis of the Global SBMA DatasetSpencer B Huggett, Andrew T N Tebbenkamp, Carlo Rinaldi, et al.
Pageof 1